Amgen Inc. (AMGN)

$ 336.29
   
  • Change Today:
    $6.70
  • 52 Week High: $387.62
  • 52 Week Low: $262.28
  • Currency: US Dollars
  • Shares Issued: 538.80m
  • Volume: 3,119,091
  • Market Cap: $181,193m
  • RiskGrade: 100
  • Beta: 0.02

Latest ShareCast News

Amgen buys UK biotech Dark Blue Therapeutics for up to $840m

By Michele Maatouk

Date: Tuesday 06 Jan 2026

(Sharecast News) - US biotech firm Amgen said on Tuesday that it has bought Dark Blue Therapeutics, a UK biotechnology company specialising in cancer treatments, for up to $840m.

EU approves AstraZeneca's Tezspire to treat nasal conditions

By Frank Prenesti

Date: Monday 22 Sep 2025

(Sharecast News) - AstraZeneca and Amgen on Monday said their Tezspire drug has been recommended for approval in the European Union for the treatment of adult patients with chronic rhinosinusitis with nasal polyps.

Horizon Therapeutics tanks as FTC expected to challenge Amgen deal

By Michele Maatouk

Date: Tuesday 16 May 2023

(Sharecast News) - Horizon Therapeutics tumbled in pre-market trade on Tuesday following a report that its $27.8bn takeover by Amgen will be challenged by federal regulators.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Amgen Inc. Market Data

Currency US Dollars
Share Price $ 336.29
Change Today $ 6.70
% Change 2.03 %
52 Week High $387.62
52 Week Low $262.28
Volume 3,119,091
Shares Issued 538.80m
Market Cap $181,193m
Beta 0.02
RiskGrade 100

What The Brokers Say

Strong Buy 7
Buy 8
Neutral 14
Sell 2
Strong Sell 1
Total 32
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for 12-May-2026

Time Volume / Share Price
16:00 186 @ $336.22
15:59 382 @ $336.29
15:59 40 @ $336.27
15:59 40 @ $336.27
15:59 58 @ $336.25

Top of Page